Basic information Safety Supplier Related

β-Hydroxypyruvic acid

Basic information Safety Supplier Related

β-Hydroxypyruvic acid Basic information

Product Name:
β-Hydroxypyruvic acid
Synonyms:
  • 3-hydroxy-2-oxopropanoic acid
  • β-hydroxypyruvic acid
  • 3-HYDROXY-2-OXOPROPIONICACID
  • Decanoic acid, ester with 2-ethyl-2-(hydroxymethy)-1,3-propanediol octanoate
  • -Hydroxypyruvic acid
  • 3-Hydroxypyruvate
  • hydroxypyruvic aci
  • 3-HYDROXYPYRUVIC ACID
CAS:
1113-60-6
MF:
C3H4O4
MW:
104.06
Mol File:
1113-60-6.mol
More
Less

β-Hydroxypyruvic acid Chemical Properties

Melting point:
202℃ (ethanol )
Boiling point:
252.9±23.0 °C(Predicted)
Density 
1.546±0.06 g/cm3(Predicted)
FEMA 
3843 | 3-HYDROXY-2-OXOPROPIONIC ACID
storage temp. 
2-8°C
solubility 
10mg/mL in PBS, pH7.2
pka
2.19±0.54(Predicted)
form 
Solid
color 
Off-white to light brown
Odor
at 1.00 % in propylene glycol. sour radish cabbage
Odor Type
sour
JECFA Number
635
LogP
-2.04
More
Less

Safety Information

Hazard Codes 
C
Risk Statements 
22-34
Safety Statements 
26-36/37/39-45
RIDADR 
UN3261 8/PG 3
WGK Germany 
3
More
Less

β-Hydroxypyruvic acid Usage And Synthesis

Chemical Properties

White crystalline powder. Boiling point 257°C. Soluble in water (50g/L, 20°C) and white oil (<100g/kg, 20°C).

Occurrence

Reported found in blue cheese, provolone cheese, beer and cocoa

Uses

β-Hydroxypyruvic Acid is a metabolite involved in the pathway of carbon in photorespiration. It can also be used to treat fiber.

Definition

ChEBI: A 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a hydroxy group. It is an intermediate involved in the glycine and serine metabolism.

Biochem/physiol Actions

Metabolite involved in the pathway of carbon in photorespiration.

in vivo

Hydroxypyruvic acid (intravenous injection; 100 mg/ml; slowly over 10 min) increases the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) in control rats, in addition, it increases to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats[1].

Animal Model:SD rat[1]
Dosage:100 mg/ml; slowly over 10 min
Administration:Intravenous injection
Result:Led to a significant increase of urinary oxalate and glycolate excretion in both control and vitamin-B6-deficient rats, but these changes are exaggerated in the vitamin-B6-deficient group.

IC 50

Human Endogenous Metabolite

β-Hydroxypyruvic acidSupplier

VDM Biochemicals
Tel
0330-2528181
Email
sales@vdmbio.com
Shanghai Macklin Biochemical Co.,Ltd.
Tel
15221275939
Email
shenlinxing@macklin.cn
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com